Financial Year |
March 31 2023 |
Monetary Funds |
172,752,041.22 |
Held-for-trading Financial Assets |
1,549,899.04 |
Notes Receivable |
169,015.04 |
Accounts Receivable |
402,702,634.17 |
Advances to Suppliers |
38,465,328.43 |
Other Receivables |
49,022,747.73 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
374,187,419.59 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
15,486,535.51 |
Total Current Assets |
1,069,896,914.20 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
19,531,265.59 |
Investment Properties |
-- |
Fixed Assetes |
170,796,956.17 |
Under-construction Projects |
7,591,540.72 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
66,192,360.17 |
R&D expenses |
-- |
Goodwill |
22,562,015.38 |
Long-Term Deferred and Prepaid Expenses |
103,990.21 |
Deferred Income Tax Assets |
2,892,086.14 |
Other Non-Current Assets |
52,801,659.47 |
Sub-Total of Non-Current Assets |
347,640,144.42 |
Total Assets |
1,417,537,058.62 |
Short-Term Loans |
14,678,777.67 |
Trading Financial liabilities |
-- |
Notes Payable |
20,000,000.00 |
Accounts Payable |
100,140,671.74 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
8,325,197.21 |
Taxes Payable |
8,549,843.76 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,016,514.51 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
109,536.29 |
Other Current Liabilities |
5,245,218.72 |
Sub-Total of Current Liabilities |
392,327,553.39 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
70,896,037.64 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
81,091,037.74 |
Total Liabilities |
473,418,591.13 |
Paid-In Capital(Or Share Stock) |
406,520,007.00 |
Capital Surplus |
1,960,484,877.68 |
Surplus Reserve |
26,541,316.03 |
LESS:Treasury Stock |
40,000,523.80 |
Undistributed Profits |
-1,437,589,583.14 |
Minority Stockholder's Interest |
28,162,373.72 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
915,956,093.77 |
Owner's Equity(Stockholder's Equity) |
944,118,467.49 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,417,537,058.62 |